| Financial Year |
March 31 2023 |
| Monetary Funds |
1,281,825,787.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,447,142.18 |
| Accounts Receivable |
188,548,824.72 |
| Advances to Suppliers |
37,498,774.67 |
| Other Receivables |
4,928,624.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,849,865.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,992,992.00 |
| Total Current Assets |
1,755,101,778.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,933,326.76 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
510,351,369.23 |
| Under-construction Projects |
683,869,029.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,689,318.80 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,638,952.53 |
| Deferred Income Tax Assets |
64,223,127.14 |
| Other Non-Current Assets |
51,381,934.69 |
| Sub-Total of Non-Current Assets |
1,490,943,301.27 |
| Total Assets |
3,246,045,079.45 |
| Short-Term Loans |
250,078,194.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
36,117,066.80 |
| Accounts Payable |
125,306,048.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,011,100.19 |
| Taxes Payable |
10,625,361.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,036,464.79 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,014,629.70 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
532,360,453.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
174,657,669.34 |
| Deferred Income Tax Liabilities |
4,317,234.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
180,576,213.27 |
| Total Liabilities |
712,936,666.80 |
| Paid-In Capital(Or Share Stock) |
108,166,667.00 |
| Capital Surplus |
2,076,630,766.26 |
| Surplus Reserve |
42,777,305.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
305,533,674.05 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,533,108,412.65 |
| Owner's Equity（Stockholder's Equity） |
2,533,108,412.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,246,045,079.45 |
